Synthomer plc (LON:SYNT – Get Rating) has been given an average recommendation of “Hold” by the seven brokerages that are covering the company, MarketBeat Ratings reports. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating and four have issued a buy rating on the company. The average 1 year price objective among brokerages that have updated their coverage on the stock in the last year is GBX 514 ($6.14).
Separately, Barclays lowered shares of Synthomer to an “equal weight” rating and cut their target price for the company from GBX 420 ($5.02) to GBX 323 ($3.86) in a report on Thursday, June 16th.
Insiders Place Their Bets
In other Synthomer news, insider Holly Van Deursen purchased 9,000 shares of the company’s stock in a transaction that occurred on Tuesday, May 3rd. The shares were purchased at an average cost of GBX 308 ($3.68) per share, with a total value of £27,720 ($33,138.08).
Synthomer Trading Down 1.4 %
Synthomer plc operates as a specialty chemicals company. It operates through four segments: Performance Elastomers, Functional Solutions, Industrial Specialities, and Acrylate Monomers. The company offers pressure sensitive adhesives, acrylic polymers, acrylic dispersions, saturants, release coatings, and other adhesives; water-based carboxylated styrene butadiene rubber, redispersible powder, flooring adhesive, and additives for construction applications; and impregnation binders, styrene butadiene copolymers, dispersions, polymer binders, and butadiene-based binders for textiles applications.
- How to Find and Determine Which Stocks Are Worth Holding Through a Bear Market
- Trip Advisor Stock Might Be Ready for a Ride
- Snowflake Stock May Have Stopped Falling
- Three Watchlist Stocks to Capitalize on Sector Rotation
- MarketBeat: Week in Review 7/18 – 7/22
Receive News & Ratings for Synthomer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synthomer and related companies with MarketBeat.com's FREE daily email newsletter.